Position in TNGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$97,317,622
+$42,221,119 QoQ
Shares Held
4,651,894
-25.2% QoQ
Ownership
3.22%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 11.915963691348082.ToString("F0")%
Shared 0.ToString("F0")%
None 88.08403630865192.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. TNGX ranks #69 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in TNGX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $97,317,622 | 4,651,894 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $55,096,503 | 6,218,567 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $28,267,722 | 3,365,205 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,079,352 | 1,382,686 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,567,886 | 1,144,443 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,804,404 | 1,231,199 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $17,850,201 | 2,318,208 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $15,686,462 | 1,828,259 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $22,756,818 | 2,866,098 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,691,486 | 978,938 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $10,740,677 | 953,879 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,984,477 | 898,939 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,245,039 | 821,529 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,118,050 | 843,869 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $3,158,819 | 872,602 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $3,362,782 | 742,336 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,873,275 | 247,134 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,516,123 | 229,993 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,561,433 | 198,100 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||